Skip to content
DataLookout
Menu

PRORADNOR-ReIRNCT07922967

Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Tolerability -patient-reported dysphagia measured with EORTC QLQ-HN43 dysphagia scale
Timeframe: From enrollment untill 6 Months post-treatment

Secondary (5)

Loco-regional control
Disease free survival
Overall survival
Health-related quality of life measured with EORTC QLQ-C30
Adverse events

Arms and interventions

Recurrance/second primay disease of HNC

Radiation: Proton radiotherapy

Sites

4 sites in 1 country